Chindex International (CHDX) 23.74 $CHDX
Chindex International, Inc. Reports First Quarter 2014 Financial Results
PR Newswire - Thu May 08, 6:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing premium quality healthcare services in China through the operations of United Family Healthcare ("UFH"
, a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the first quarter ended March 31, 2014.
Chindex Signs Previously-Disclosed Joint Venture Regarding Guangzhou United Family Hospital
PR Newswire - Tue May 06, 3:01PM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company" , an American healthcare company providing healthcare services in China through the operations of United Family Healthcare ("UFH" , a network of private hospitals and affiliated ambulatory clinics, signed an agreement today with the Guangdong Provincial Hospital of Traditional Chinese Medicine ("Guangdong Provincial TCM Hospital" to establish a joint venture company that will operate the full-service, international-standard Guangzhou United Family Hospital ("GZU" already under construction in downtown Guangzhou, China. The Hospital is scheduled to complete construction and open in early 2016.
42.6% Return Seen to Date on SmarTrend Chindex International Call (CHDX)
Comtex SmarTrend(R) - Mon May 05, 5:07PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 42.63% as of today's recent price of $23.82.
Chindex International, Inc. to Report First Quarter 2014 Financial Results
PR Newswire - Wed Apr 30, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company plans to release financial results for the first quarter of 2014, ended March 31, 2014, on Thursday, May 8, 2014 before the market opens. Management will host a conference call at 9:00 AM ET on the same day to discuss financial results.
Uptrend Call Working As Chindex International Stock Rises 41.8% (CHDX)
Comtex SmarTrend(R) - Mon Apr 28, 10:57AM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 41.80% as of today's recent price of $23.68.
The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of Directors
Business Wire - Thu Apr 24, 5:50PM CDT
The Alexander Firm P.C., A Professional Law Corporation, announces that it is investigating potential claims for breach of fiduciary duty against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company" (NASDAQ:CHDX) concerning the proposed acquisition of the Company by an affiliate of TPG, Fosun Industrial Co., Limited (which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson, the CEO of the Company (the "Buyer Consortium" . According to the Company, the transaction is currently valued at $24.00 per share in cash and implied equity value of $461 million.
Dividends, Drug Trends Report, Upcoming Financial Results, Earnings Results, and Superior Proposal Receipt - Analyst Notes on Walgreens, CVS Caremark, Rite Aid, Cardinal Health, and Chindex
PR Newswire - Tue Apr 22, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Walgreen Co. (NYSE: WAG), CVS Caremark Corporation (NYSE: CVS), Rite Aid Corp. (NYSE: RAD), Cardinal Health, Inc. (NYSE: CAH), and Chindex International Inc. (NASDAQ: CHDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Chindex International Up 41.6% Since SmarTrend Uptrend Call (CHDX)
Comtex SmarTrend(R) - Mon Apr 21, 9:41AM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 41.65% as of today's recent price of $23.66.
Chindex Signs Amended Merger Agreement with TPG and Fosun Pharma -- Increases Consideration from $19.50 to $24.00 per Share in Cash and Implied Equity Value from $369 Million to $461 Million
PR Newswire - Mon Apr 21, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company" , an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, announced that it has entered into an amended and restated merger agreement (the "Amended Agreement" relating to the merger (the "Merger" among the Company, the existing buyer consortium (the "Buyer Consortium" comprised of an affiliate of TPG (together with its affiliates, "TPG" , Fosun Industrial Co., Limited ("Fosun" , which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" , and Ms. Roberta Lipson, the CEO of the Company, and a merger subsidiary of the Buyer Consortium providing for an increase in the merger consideration from $19.50 per share in cash to $24.00 per share in cash.
3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Apr 17, 3:25PM CDT
It may seem like the market has pummeled momentum stocks over the past month, but with one-third of all stocks in The Motley Fool CAPS database sitting within 10% of a fresh 52-week high, a good number of investors would beg to differ. For skeptics...
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP is Investigating the Chindex International (CHDX) Board of Directors for Potential Breaches of Fiduciary Duties
Business Wire - Thu Apr 17, 2:27PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is examining claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company" (Nasdaq:CHDX) for potential breaches of fiduciary duties in connection with the superior bid for the Company by an unidentified bidder.
Medtronic Inc. Barred from Selling Artificial Heart Valve to Most Patients in U.S; Chindex Receives Cash Offer at $23 a Share
ACCESSWIRE - Mon Apr 14, 11:39PM CDT
Medtronic, Inc. (NYSE: MDT) - For an in-depth report on Medtronic, Inc. follow www.BullTrends.com/stockquote/MDT
Chindex International, Inc. Board of Directors Under Investigation by Glancy Binkow & Goldberg LLP
Business Wire - Mon Apr 14, 7:00PM CDT
Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company" (NASDAQ:CHDX) related to the bid for the Company by an unidentified bidder ("Bidder" . The proposed transaction is valued in excess of $435 million, and under the terms of the deal shareholders of the Company will receive $23.00 in cash for each common share of Chindex owned.
Nasdaq stocks posting largest volume increases
AP - Mon Apr 14, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 14, 5:01PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Chindex (CHDX) Stock Is Soaring Today
at The Street - Mon Apr 14, 10:34AM CDT
Chindex (CHDX) shares are up in trading on Monday following a higher bid offer for its outstanding common stock shares
Chindex Announces Receipt of Superior Proposal
PR Newswire - Mon Apr 14, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company" , an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced the receipt of an offer from a financial bidder to acquire all of the outstanding shares of Chindex common stock for $23 per share in cash.
Chindex International Shares Up 17.2% Since SmarTrend's Buy Recommendation (CHDX)
Comtex SmarTrend(R) - Thu Apr 10, 5:04PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 17.25% as of today's recent price of $19.58.
Chindex Announces End of 'Go-Shop' Period; Board Transaction Committee Designates an Excluded Person
PR Newswire - Mon Apr 07, 7:06AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company" , an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced the expiration on April 3, 2014 of the 45-day "go-shop" period provided for under the terms of the previously announced merger agreement (the "Merger Agreement" between the Company and a buyer consortium (the "Buyer Consortium" comprised of an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson, the CEO of the Company.
Chindex International, Inc. Reports First Quarter 2014 Financial Results
PR Newswire - Thu May 08, 6:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing premium quality healthcare services in China through the operations of United Family Healthcare ("UFH"
, a network of private primary care hospitals and affiliated ambulatory clinics, today announced financial results for the first quarter ended March 31, 2014. Chindex Signs Previously-Disclosed Joint Venture Regarding Guangzhou United Family Hospital
PR Newswire - Tue May 06, 3:01PM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"
, an American healthcare company providing healthcare services in China through the operations of United Family Healthcare ("UFH" , a network of private hospitals and affiliated ambulatory clinics, signed an agreement today with the Guangdong Provincial Hospital of Traditional Chinese Medicine ("Guangdong Provincial TCM Hospital" to establish a joint venture company that will operate the full-service, international-standard Guangzhou United Family Hospital ("GZU" already under construction in downtown Guangzhou, China. The Hospital is scheduled to complete construction and open in early 2016. 42.6% Return Seen to Date on SmarTrend Chindex International Call (CHDX)
Comtex SmarTrend(R) - Mon May 05, 5:07PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 42.63% as of today's recent price of $23.82.
Chindex International, Inc. to Report First Quarter 2014 Financial Results
PR Newswire - Wed Apr 30, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company plans to release financial results for the first quarter of 2014, ended March 31, 2014, on Thursday, May 8, 2014 before the market opens. Management will host a conference call at 9:00 AM ET on the same day to discuss financial results.
Uptrend Call Working As Chindex International Stock Rises 41.8% (CHDX)
Comtex SmarTrend(R) - Mon Apr 28, 10:57AM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 41.80% as of today's recent price of $23.68.
The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of Directors
Business Wire - Thu Apr 24, 5:50PM CDT
The Alexander Firm P.C., A Professional Law Corporation, announces that it is investigating potential claims for breach of fiduciary duty against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company"
(NASDAQ:CHDX) concerning the proposed acquisition of the Company by an affiliate of TPG, Fosun Industrial Co., Limited (which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson, the CEO of the Company (the "Buyer Consortium" . According to the Company, the transaction is currently valued at $24.00 per share in cash and implied equity value of $461 million. Dividends, Drug Trends Report, Upcoming Financial Results, Earnings Results, and Superior Proposal Receipt - Analyst Notes on Walgreens, CVS Caremark, Rite Aid, Cardinal Health, and Chindex
PR Newswire - Tue Apr 22, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Walgreen Co. (NYSE: WAG), CVS Caremark Corporation (NYSE: CVS), Rite Aid Corp. (NYSE: RAD), Cardinal Health, Inc. (NYSE: CAH), and Chindex International Inc. (NASDAQ: CHDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Chindex International Up 41.6% Since SmarTrend Uptrend Call (CHDX)
Comtex SmarTrend(R) - Mon Apr 21, 9:41AM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 41.65% as of today's recent price of $23.66.
Chindex Signs Amended Merger Agreement with TPG and Fosun Pharma -- Increases Consideration from $19.50 to $24.00 per Share in Cash and Implied Equity Value from $369 Million to $461 Million
PR Newswire - Mon Apr 21, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"
, an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, announced that it has entered into an amended and restated merger agreement (the "Amended Agreement" relating to the merger (the "Merger" among the Company, the existing buyer consortium (the "Buyer Consortium" comprised of an affiliate of TPG (together with its affiliates, "TPG" , Fosun Industrial Co., Limited ("Fosun" , which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" , and Ms. Roberta Lipson, the CEO of the Company, and a merger subsidiary of the Buyer Consortium providing for an increase in the merger consideration from $19.50 per share in cash to $24.00 per share in cash. 3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Apr 17, 3:25PM CDT
It may seem like the market has pummeled momentum stocks over the past month, but with one-third of all stocks in The Motley Fool CAPS database sitting within 10% of a fresh 52-week high, a good number of investors would beg to differ. For skeptics...
CHINDEX INTERNATIONAL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP is Investigating the Chindex International (CHDX) Board of Directors for Potential Breaches of Fiduciary Duties
Business Wire - Thu Apr 17, 2:27PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is examining claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company"
(Nasdaq:CHDX) for potential breaches of fiduciary duties in connection with the superior bid for the Company by an unidentified bidder. Medtronic Inc. Barred from Selling Artificial Heart Valve to Most Patients in U.S; Chindex Receives Cash Offer at $23 a Share
ACCESSWIRE - Mon Apr 14, 11:39PM CDT
Medtronic, Inc. (NYSE: MDT) - For an in-depth report on Medtronic, Inc. follow www.BullTrends.com/stockquote/MDT
Chindex International, Inc. Board of Directors Under Investigation by Glancy Binkow & Goldberg LLP
Business Wire - Mon Apr 14, 7:00PM CDT
Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Chindex International, Inc. ("Chindex" or the "Company"
(NASDAQ:CHDX) related to the bid for the Company by an unidentified bidder ("Bidder" . The proposed transaction is valued in excess of $435 million, and under the terms of the deal shareholders of the Company will receive $23.00 in cash for each common share of Chindex owned. Nasdaq stocks posting largest volume increases
AP - Mon Apr 14, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Mon Apr 14, 5:01PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Why Chindex (CHDX) Stock Is Soaring Today
at The Street - Mon Apr 14, 10:34AM CDT
Chindex (CHDX) shares are up in trading on Monday following a higher bid offer for its outstanding common stock shares
Chindex Announces Receipt of Superior Proposal
PR Newswire - Mon Apr 14, 7:00AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"
, an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced the receipt of an offer from a financial bidder to acquire all of the outstanding shares of Chindex common stock for $23 per share in cash. Chindex International Shares Up 17.2% Since SmarTrend's Buy Recommendation (CHDX)
Comtex SmarTrend(R) - Thu Apr 10, 5:04PM CDT
SmarTrend identified an Uptrend for Chindex International (NASDAQ:CHDX) on December 24th, 2013 at $16.70. In approximately 4 months, Chindex International has returned 17.25% as of today's recent price of $19.58.
Chindex Announces End of 'Go-Shop' Period; Board Transaction Committee Designates an Excluded Person
PR Newswire - Mon Apr 07, 7:06AM CDT
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"
, an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced the expiration on April 3, 2014 of the 45-day "go-shop" period provided for under the terms of the previously announced merger agreement (the "Merger Agreement" between the Company and a buyer consortium (the "Buyer Consortium" comprised of an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Ms. Roberta Lipson, the CEO of the Company. 
